Petco Health and Wellness financials
$2.28+0.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '27 Aug 1 | Q1 '27 May 2 | Q4 '26 Jan 31 | Q3 '26 Nov 1 | Q2 '26 Aug 2 | Q1 '26 May 3 | Q4 '25 Feb 1 | Q3 '25 Nov 2 | Q2 '25 Aug 3 | Q1 '25 May 4 | Q4 '24 Feb 3 | Q3 '24 Oct 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.52B | $1.46B | $1.49B | $1.49B | $1.55B | $1.51B | $1.52B | $1.53B | $1.67B | $1.49B |
| Gross profit | $591.1M | $574.4M | $580.8M | $569.0M | $585.3M | $570.0M | $589.3M | $575.8M | $580.7M | $578.7M | $606.3M | $550.0M |
| Gross margin | 39.7% | 38.4% | 38.3% | 38.9% | 39.3% | 38.2% | 38.0% | 38.1% | 38.1% | 37.8% | 36.2% | 36.8% |
| Operating income | $47.8M | $24.6M | $31.9M | $29.2M | $43.0M | $16.4M | $17.4M | $4.0M | $2.5M | -$16.8M | $166.0K | -$1.23B |
| Net income | $38.7M | -$15.1M | -$2.6M | $9.3M | $14.0M | -$11.7M | -$13.8M | -$16.7M | -$24.8M | -$46.5M | -$22.6M | -$1.24B |
| Net margin | 2.6% | −1.0% | −0.2% | 0.6% | 0.9% | −0.8% | −0.9% | −1.1% | −1.6% | −3.0% | −1.3% | −83.1% |
| Diluted EPS | $0.13 | $-0.05 | $-0.01 | $0.03 | $0.05 | $-0.04 | $-0.05 | $-0.06 | $-0.09 | $-0.17 | $-0.08 | $-4.63 |
| EBITDA | $98.2M | $73.7M | $80.1M | $79.0M | $92.4M | $66.2M | $76.5M | $54.1M | $52.2M | $32.8M | $166.0K | $41.1M |
| Operating cash flow | $161.6M | -$31.0M | $153.5M | $90.1M | $85.9M | -$15.5M | $96.0M | $20.7M | $69.4M | -$8.4M | $47.0M | $34.4M |
| Free cash flow | $129.9M | -$69.1M | $116.4M | $60.6M | $53.8M | -$43.9M | $59.0M | -$10.3M | $42.0M | -$41.1M | -$2.0M | -$28.1M |
| Diluted shares | 290.5M | 283.7M | 293.1M | 288.2M | 285.7M | 277.5M | 276.3M | 274.5M | 273.1M | 269.8M | 268.7M | 267.9M |
Balance sheet
| Period end | Aug 1 | May 2 | Jan 31 | Nov 1 | Aug 2 | May 3 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $293.5M | $166.8M | $256.7M | $237.4M | $188.7M | $133.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.48B | $1.48B | $1.49B | $1.59B | $1.59B | $1.58B |
| Total assets | $5.17B | $5.08B | $5.17B | $5.21B | $5.15B | $5.12B |
| Total liabilities | $3.96B | $3.93B | $4.01B | $4.05B | $4.01B | $4.01B |
| Shareholders' equity | $1.21B | $1.16B | $1.16B | $1.16B | $1.14B | $1.11B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology